Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
HIKAL | NSE
-6.03
-3.22%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
24/04/2026
181.10
188.37
188.37
179.50
Hikal Limited together with its subsidiaries manufactures and sells various chemical intermediates specialty chemicals and active pharma ingredients to pharmaceutical animal healthcare biotech crop protection and specialty chemicals companies. It operates through two segments Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research custom synthesis and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives as well as additives for leather paint coatings paper water treatment personal care building materials and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai India.
View LessPrice Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
31.8%1 month
54.5%3 months
53.7%6 months
46.1%69.03
16.75
3.83
0.69
0.33
20.06
3.02
-
2.73B
22.33B
233.38M
0.32
6.44
-26.80
4.80
6.00
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
21.58
Range1M
48.54
Range3M
76.55
Rel. volume
0.72
Price X volume
47.25M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Alembic Limited | ALEMBICLTD | Drug Manufacturers-Specialty & Generic | 91.42 | 23.56B | -2.15% | 12.29 | 0.42% |
| Morepen Laboratories Limited | MOREPENLAB | Drug Manufacturers-Specialty & Generic | 41.72 | 23.05B | -2.27% | 37.53 | 3.42% |
| Panacea Biotec Limited | PANACEABIO | Biotechnology | 368.55 | 23.00B | 3.38% | n/a | 2.49% |
| SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 477.5 | 20.69B | -4.24% | n/a | 107.90% |
| Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 206.34 | 19.01B | -3.48% | 42.22 | 60.54% |
| Windlas Biotech Limited | WINDLAS | Drug Manufacturers-Specialty & Generic | 860.05 | 18.04B | -3.86% | 35.85 | 0.81% |
| Amrutanjan Health Care Limited | AMRUTANJAN | Drug Manufacturers-Specialty & Generic | 576.55 | 16.67B | -0.46% | 52.36 | 0.60% |
| Venus Remedies Limited | VENUSREM | Drug Manufacturers-Specialty & Generic | 949.6 | 12.69B | -5.00% | 16.58 | 8.48% |
| Hester Biosciences Limited | HESTERBIO | Drug Manufacturers-Specialty & Generic | 1492 | 12.69B | 1.00% | 104.15 | 83.75% |
| Lincoln Pharmaceuticals Ltd | LINCOLN | Drug Manufacturers-Specialty & Generic | 605.55 | 12.13B | -0.96% | 13.55 | 0.18% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 105.44 | 15.54B | -1.25% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 261.58 | 15.33B | -2.64% | 30.54 | 80.30% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 203.06 | 7.24B | -2.11% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 219.34 | 7.09B | 1.49% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 59 | 1.63B | -1.55% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 89.31 | 1.30B | -1.13% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 75.31 | 839.62M | 0.39% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 23.58 | 409.35M | -2.16% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 7.29 | 159.72M | 0.00% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 20.06 | 24.85 | Par |
| Ent. to Revenue | 3.02 | 11.40 | Cheaper |
| PE Ratio | 69.03 | 51.36 | Expensive |
| Price to Book | 3.83 | 6.83 | Cheaper |
| Dividend Yield | 0.32 | 0.52 | Poor |
| Std. Deviation (3M) | 53.71 | 42.17 | Riskier |
| Debt to Equity | 0.69 | 0.35 | Expensive |
| Debt to Assets | 0.33 | 0.17 | Expensive |
| Market Cap | 22.33B | 290.82B | Emerging |